Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,914.00
Bid: 10,918.00
Ask: 10,922.00
Change: 52.00 (0.48%)
Spread: 4.00 (0.037%)
Open: 10,946.00
High: 11,018.00
Low: 10,858.00
Prev. Close: 10,862.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Promising Start Amid Blue-Chip Exec Changes

Fri, 22nd Nov 2019 08:52

(Alliance News) - Stocks in London were broadly higher early Friday, after China said it wants a trade deal with US, though it did not shy away from fighting talk, and Land Securities and Rightmove both announced key executive changes.

The FTSE 100 index of London large-cap stocks was 59.31 points higher, or 0.8%, at 7,297.86 on Friday morning. The mid-cap FTSE 250 was 15.20 points up, or 0.1%, at 20,385.06, but the AIM All-Share was 0.2% higher at 904.07.

The Cboe UK 100 index was 1.0% higher at 12,383.68. The Cboe UK 250 was 0.5% up early on Friday at 18,354.37, but the Cboe UK Small Companies was marginally lower at 11,272.21.

Property developer Land Securities was 0.6% higher after it said Mark Allan will join as chief executive after leaving his role as CEO of St Modwen Properties in May next year. Allan was formerly was the CEO of student accommodation provider Unite Group between 2006 and 2016, Landsec noted.

He is to join the FTSE 100 firm "no later than June 1, 2020", Landsec added.

St Modwen, down 1.5%, making it one of the worst FTSE 250 performers, said it was "disappointed" to lose Allan but has begun the process to replace him.

Also making a key executive change was real estate firm Rightmove, up 1.0% in early dealings, naming Andrew Fisher as non-executive chair with effect on January 1. He is currently a non-executive director at retailer Marks & Spencer and insurance comparison site Moneysupermarket.com, and was formerly executive chair at music recognition mobile app Shazam.

FTSE 250 gambling software firm Playtech was down 1.8% early on Friday after it warned adjusted earnings before interest, tax, depreciation and amortisation will be "a little below consensus" in 2019.

The company, which provides betting terminals for the likes of Labrokes and Paddy Power, said: "Following a positive start to the second half, trading conditions in TradeTech have been highly challenging during September and October."

However, Playtech said trading in its Core B2B Gambling and Snaitech arms "continues to exceed management expectations, while trading in Asia has remained stable". Revenue in Regulated B2B Gambling was up 12% on a year before in the four months from July to October.

Also issuing a full-year earnings warning was Coats Group, down 11% and languishing at the foot of the FTSE 250 index.

On the back of a "slower sales performance", the industrial threads maker is now guiding for adjusted operating profit between USD196 million and USD201 million.

Adjusted operating profit in 2018 came in at USD195 million.

Elsewhere on the London Main Market, investment manager Brooks Macdonald said it will part with up to GBP39 million in cash to acquire Edinburgh-based Cornelian Asset Managers.

Brooks said: "The total net consideration is expected to be up to GBP39 million, with initial consideration being GBP31 million, of which GBP22 million will be paid in cash and GBP9m in Brooks Macdonald shares."

Brooks will launch a share placing to raise GBP30 million. The firm will price its shares at 1,775 pence apiece. The stock was down 1.9% at 1,790.0 pence each.

Pharma giant AstraZeneca edged 1.0% higher following Thursday's late news that its drug Calquence had been approved in the US for adults patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.

The approval by the US Food & Drug Administration results from positive analyses from two phase 3 clinical trials, Elevate-TN in patients with previously untreated CLL and Ascend in patients with relapsed or refractory CLL.

In European equities, the CAC 40 index in Paris was up 0.6% and the DAX 30 in Frankfurt also 0.6% higher.

Stocks in the US ended in the red on Thursday. The S&P 500, the Dow Jones Industrial Average and Nasdaq Composite all closed 0.2% lower.

Stocks in Asia were mixed on Friday, the Nikkei 225 closed 0.3% higher in Tokyo, with Hong Kong's Hang Seng 0.5% higher in late trade. The Shanghai Composite closed 0.6% lower in China.

"Global markets remained focused on US-China trade negotiations, taking a modicum of comfort on reports that Chinese VP Liu has invited US Trade Rep Lighthizer to Beijing for further talks," Lloyds bank research said.

On Friday, President Xi Jinping said China wanted to hammer out a deal but was "not afraid" to fight back when necessary. He told former US officials and other foreign dignitaries at a meeting in Beijing that he wanted to "work for a phase-one agreement on the basis of mutual respect and equality".

The remarks came two days after Donald Trump complained Beijing had not made sufficient concessions so far, making him reluctant to conclude a bargain.

Mining stocks in London received a slight uptick following the latest trade war developments.

Antofagasta topped the blue-chip index, rising 2.5% early on Friday. Glencore was just behind, 2.4% higher, with BHP and Rio Tinto both up 1.7%.

A slew of flash PMI readings will provide some distraction from the trade tit-for-tat, with manufacturing and services numbers from Japan, Germany, the eurozone, the UK and the US.

In Japan, the Jibun Bank flash composite PMI registered a slight rise in November but pointed to a "strongly possibility" the country's economy will contract in the fourth quarter.

The flash composite purchasing manager's index read 49.9 in November, up from October's actual figure of 49.1. The flash manufacturing PMI showed a slight rise to 48.6 in November from 48.4 the previous month, while the flash services PMI indicated a rise into expansionary territory, increasing to 50.4 from 49.7.

In Germany, the flash composite PMI was 49.2 in November, up from 48.9 in October. The manufacturing PMI improved, but services slipped a bit.

The eurozone reading is due at 0900 GMT, before the UK reading at 0930 GMT.

"We look for a small decline in the November manufacturing PMI to 49.0, but a rise in the services PMI to 50.5. These numbers remain consistent with flat or slightly negative quarterly growth," Lloyds said, ahead of the UK print.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
Today 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.